Lv43
600 积分 2025-07-03 加入
Prevention of heart failure after acute myocardial infarction
1小时前
待确认
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
7天前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
8天前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
8天前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
9天前
已关闭
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
10天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
13天前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
13天前
已完结
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
27天前
已完结
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
27天前
已完结
皖公网安备34019202002308
